Shorter and safer treatment for latent TB
Part of Infections clinical trials.
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 5 years old or older and weigh more than 15 kg (about 33 pounds).
- You have a positive test for TB infection (like a skin test or blood test).
- You do not have active TB disease currently.
- You are not pregnant or breastfeeding.
- You have not been treated for TB infection or disease before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests shorter treatments for tuberculosis (TB) and TB infection using the drug rifapentine. If you have TB or are at risk of developing it, this trial may help you finish treatment faster.
This trial studies whether taking rifapentine every day is safe and helps prevent active tuberculosis (TB) in people who have latent TB infection. It aims to find the best way to stop TB from becoming a serious illness later.
This trial tests whether a shorter, rifampicin-based treatment works well for people with less severe TB in the lungs. If you have limited TB that is sensitive to rifampicin, you might be able to take medicine for a shorter time than usual.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
This trial tests if a shorter treatment course works as well as the standard one for people whose chest X-rays suggest TB but whose sputum tests are negative. It aims to make treatment easier for patients.
This trial tests two shorter treatments (1HP or 3HR) to prevent TB infection from becoming active disease. It is for adults who live with someone who has drug-sensitive TB and have a positive test for TB infection.
Hear when a new Tuberculosis Infection, Latent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.